Apparently, the complete loss of Bcl9/Bcl9L impairs survival of mammary tumor cells, while the disruption of the β-catenin-Bcl9/Bcl9L-Pygopus chain of adapters only affects the tumorigenic behavior of the tumor cells. Here, BCL9 is linked to breast cancer.